Medtronic Recalls Mini Med and Pro Infusion Insulin Pumps due to Life-Threatening Injuries
The MiniMed 600 series Insulin Pump System (630G and 670G) and its Pro Infusion Sets, in particular, is an example of this device used for diabetes management. Manufactured and distributed by Medtronic, the product appeared to be an effective therapy for diabetic patients. However, in response to numerous adverse reports, Medtronic voluntarily provided its customers with a safety message in November 2019, describing the proper way to use the system in order to prevent the over or under-delivery of insulin. Responsively, the U.S. Food and Drug Administration (FDA) issued a Class I recall of the Medtronic MiniMed Insulin pump in February 2020, warning of possible defects that could cause a major health injury or possibly death. While Medtronic is no stranger to lawsuits from injuries caused by their malfunctioning pumps, a new wave of lawsuits on the MiniMed 600 Series Insulin pump is on the horizon as the number of injury reports continue to rapidly increase.
Insulin pumps are commonly used by diabetic patients to monitor and regulate their own blood sugar by providing continuous, yet precise variable amounts of insulin throughout the day. This computerized device – while discreet and small in size – has had a large impact in the diabetes community, primarily due to its ability to effectively mimic a healthy-functioning pancreas without the need for multiple daily self-injections of insulin. Medtronic insulin pump users depend on their pump to accurately administer the correct amount of insulin for their needs. When Medtronic insulin pump users receive too much insulin, they can go into a diabetic coma. Alternatively, if Medtronic insulin pump users do not get enough insulin, their glucose levels will soar, placing them at risk for diabetic kidney disease, neuropathy and other diabetic complications.
The Medtronic class action lawyers at Yost Legal group are actively involved in investigating defective Medtronic insulin pump lawsuits. If you or a loved one has used a Medtronic MiniMed insulin pump and experienced an adverse reaction, such as hypoglycemia, hyperglycemia, diabetic coma or developed a long-term impairment you may be entitled to compensation from Medtronic. Please call or contact us through our website for a free initial consultation at www.yostlaw.com or 1-800-YOST-LAW.
We are committed to providing solutions to your inquiries and helping you obtain a recovery for your injury.